Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Non-Current Debt (2024 - 2025)

Historic Non-Current Debt for TriSalus Life Sciences (TLSI) over the last 2 years, with Q3 2025 value amounting to $32.8 million.

  • TriSalus Life Sciences' Non-Current Debt rose 5113.94% to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 5113.94%. This contributed to the annual value of $22.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that TriSalus Life Sciences reported Non-Current Debt of $32.8 million as of Q3 2025, which was up 5113.94% from $32.3 million recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Non-Current Debt registered a high of $32.8 million during Q3 2025, and its lowest value of $21.3 million during Q2 2024.